跳至主要内容
临床试验/KCT0008233
KCT0008233招募中未知

Guideline-directed high intensity statin only therapy versus statin with ezetimibe combination therapy in patients with polyvascular disease including coronary artery disease and peripheral artery disease: a multicenter prospective randomized open-label trial

Kangbuk Samsung Medical Center0 个研究点目标入组 1,584 人开始时间: 待定最近更新:
适应症

试验速览

阶段
未知
状态
招募中
入组人数
1,584

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional Study

入排标准

年龄范围
18(Year) 至 o Limit(—)
性别
All

入选标准

  • Patients aged 18 years or older with both of the following diseases
  • 1) Coronary artery disease
  • Patients with clinically diagnosed coronary artery disease. Coronary artery disease includes stable angina pectoris, unstable angina pectoris, acute non-ST-segment elevation myocardial infarction, and acute ST-segment elevation myocardial infarction.
  • 2) Peripheral vascular disease
  • Patients who have previously undergone aortofemoral bypass surgery, limb bypass surgery, or percutaneous angioplasty of the ilium or lower artery.
  • Patients who have undergone limb or foot amputation for arterial vascular disease.
  • Patients with intermittent claudication who satisfy one or all of the following conditions
  • a) Ankle-brachial index (ABI) less than 0.9
  • b) Confirmation of 50% or more peripheral vascular stenosis by angiography or Doppler ultrasound
  • Asymptomatic patients who have undergone previous carotid artery recanalization or have carotid artery stenosis of 50% or more confirmed by angiography or Doppler ultrasound
  • - Patients who consented to the study

排除标准

  • Patients who are breastfeeding or planning to become pregnant during the study period
  • - Those with a history of serious side effects or hypersensitivity to statins
  • - Patients who are currently taking drugs with strong interactions with statins (cytochrome p-450 3A4 or 2C9 inhibitors)
  • - Those with risk factors for myopathy or rhabdomyolysis, such as hereditary muscle disorder, hypothyroidism, alcoholism, severe liver dysfunction (more than 3 times the normal value)
  • - Patients with life expectancy less than 3 years
  • - If it is judged that follow-up for more than 1 year is not possible
  • - If you cannot understand or read the consent form

研究者

相似试验

Guideline-directed high intensity statin only... | 临床试验